Ovid Therapeutics Inc. Profile Avatar - Palmy Investing

Ovid Therapeutics Inc.

Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the …

Biotechnology
US, New York [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of OVID's Analysis
CIK: 1636651 CUSIP: 690469101 ISIN: US6904691010 LEI: - UEI: -
Secondary Listings
OVID has no secondary listings inside our databases.